Rx only · Injection, Solution · Subcutaneous
Ixekizumab
Brands: Taltz · Ixekizumab
1 ACTIVE SUPPLIER - US
openFDA · updated weekly
US4 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
$7399.926
Latest avg · Aug 19, 2026
+5%
Since Jan 1, 2025
1
Active US suppliers